Related Experiment Video
Updated: Jul 6, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Membrane proteins as diagnostic biomarkers and targets for new therapies
Djuro Josic1, James G Clifton, Spomenka Kovac
1Rhode Island Hospital, COBRE Center for Cancer Research Development, Proteomics Core, Suite 4, 206 Coro West, 1 Hoppin Street, Providence, RI 02903, USA. djuro_josic@brown.edu
Abstract:
Membrane proteins, especially plasma membrane proteins, form one of the most interesting classes of proteins among disease biomarker candidates. Because of their localization on the surface of cells and organelles, membrane proteins also represent potential drug targets. In this review, developments in the characterization of membrane proteins and their role in the treatment of disease, in particular cancer treatment, are presented.
Related Concept Videos
Single-pass Transmembrane Proteins
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Membrane Proteins
Membrane Proteins
Introduction to Membrane Proteins
